drugset
drugset / Trial / NCT02755376

Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell

NCT02755376 ↗

Completed 30 enrolled Samsung Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Purpose:Development of novel strategy for treatment of anterior cruciate ligament (ACL) injury using stem cell.

Timeline

Start
2014-01-01
Primary completion
2016-04-28
Completion
2018-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cartistem(TM) Cell therapy — —
Subject Hyaluronic Acid Other / unclassified — —

Indications

No indication recorded.